First Trust Nasdaq Pharmaceuticals ETF · $1.2B$18,039
FTXHFTXH vsIBBIBBiShares Biotechnology ETF · $11.2B$13,634
$10,000 five years ago, dividends reinvested · they hold 36.4% in common
FTXHMeasureIBB
Returns · dividends reinvested
+33.8%Year to dateJan 1 → Nov 3+27.8%
+46.6%1 yearTotal return+35.5%
+24.1%3 years · per year$10,000 became $19,115 · $19,307+24.5%
+12.5%5 years · per year$10,000 became $18,039 · $13,634+6.4%
Cost and income
0.60%Expense ratio$60 · $44 a year on $10k · lower is better0.44%
0.66%Trailing 12-mo yield$66 · $16 a year on $10k0.16%
Risk · past year
−7.5%Worst dropSmaller is better−9.6%
17.7%VolatilityLower is calmer22.7%
FTXHIBB Winner of the row, in its colourEach row: the bigger of the two fills its side
6–2FTXH wins
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns